About Biorad Medisys Private Limited
Data last updated: 21 January 2026
Biorad Medisys Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 13 March 2000, the company has been in operation for over 26 years.
Registered with ROC Mumbai under CIN U33111KA2000PTC026592.
Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.22 Cr. It is led by directors including Nitin Jagannath Deshmukh and Suchitra Hegde Jitendra.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹556.96 Cr, a growth of 52% compared to the previous year.
The company has a workforce of approximately 572 employees as per the latest available data.
The company is associated with 2 brands - Indovasive, Biorad Medisys. As per MCA filings, the company has open charges of ₹800.8 Cr and satisfied charges of ₹25.24 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biorad-medisys.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressNo.221 Damji Shamji Industrial Complex Near Golden Palace Hotel 9Lbs Marg Kur, La(W), Mumbai, Maharashtra, India – 400070
-
IndustryHealthcare, Medical & Laboratory Equipment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Biorad Medisys Private Limited
Biorad Medisys Private Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U33111MH2000PTC265335, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33111MH2000PTC265335 | Current |
| U33111KA2000PTC026592 | Previous |
| U24231KA2000PTC026592 | Previous |
Associated Brands with Biorad Medisys Private Limited
Biorad Medisys Private Limited operates two associated brands: Indovasive and Biorad Medisys. These brands represent Biorad Medisys Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Medical devices and solutions for gastroenterology and urology are provided by the company. | indovasive.co.in | |
| Medical devices for orthopaedic, neurovascular, and endovascular procedures are manufactured. | bioradmedisys.com |
Competitors & Alternatives of Biorad Medisys Private Limited
Brands and companies operating in the same space as Biorad Medisys Private Limited include OrthAlign, Axial3D, Shoulder Innovations and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
OrthAlign
|
Knee and hip alignment devices and technology | Aliso Viejo, United States, United States | 2008 |
Axial3D
|
Provider of cloud-based 3D-printed medical models and surgical guides | Belfast, United Kingdom, United Kingdom | 2014 |
Shoulder Innovations
|
Total shoulder replacement solutions based on glenoid technology are provided. | Holland, United States, United States | 2009 |
Cartiva
|
Synthetic cartilage implants are developed for osteoarthritis treatment. | Alpharetta, United States, United States | 2011 |
b-ONE Ortho
|
Orthopedic-assisted surgery devices are developed for knee and hip applications. | Hanover, United States, United States | 2015 |
Conventus Flower Orthopedics
|
Developer of medical device for orthopedic diseases | Horsham, United States, United States | 2008 |
ConforMIS
|
3D-printed orthopedic products are developed for customized knee implants. | Billerica, United States, United States | 2004 |
Syntellix AG
|
Bioabsorbable metallic implants for joint reconstruction are developed. | Hannover, Germany, Germany | 2008 |
Business Activity of Biorad Medisys Private Limited
Biorad Medisys Private Limited is engaged in principal business activities including manufacturing and trade, with detailed activities including other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | ********* |
| G | Trade | G1 | Wholesale Trading | ********* |
Board of Directors of Biorad Medisys Private Limited
Biorad Medisys Private Limited is currently managed by 4 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Nitin Jagannath Deshmukh
Also directs:
Advanced Enzyme Technologies Limited, Bioneeds India Private Limited, Samta Mines And Minerals Limited and 1 more
|
Nominee Director | 24 Dec 2024 | 1 Years 6 Months | Current |
|
Suchitra Hegde Jitendra
Also directs:
Biomedicon Care Private Limited, Biomedicon Services (India) Private Limited, Indus Medical Instruments Private Limited and 4 more
|
Director | 12 Apr 2007 | 19 Years 2 Months | Current |
| Noureddine Frid | Director | 27 Sep 2024 | 1 Years 9 Months | Current |
|
Jitendra Madhava Hegde
Also directs:
Biomedicon Care Private Limited, Biomedicon Services (India) Private Limited, Indus Medical Instruments Private Limited and 4 more
|
Managing Director | 24 Jan 2007 | 19 Years 5 Months | Current |
Financials of Biorad Medisys Private Limited FY 2025 filings available
Biorad Medisys Private Limited reported revenue of ₹556.96 Cr (up 52% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Biorad Medisys Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jun 2025 | Hdfc Bank Limited | ₹30 Cr | Open |
| 28 Jan 2025 | Axis Bank Limited | ₹15 Cr | Open |
| 13 Jan 2025 | Others | ₹227.35 Cr | Open |
| 25 Oct 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹30 Cr | Open |
| 25 Jul 2024 | Others | ₹4.5 Cr | Open |
Total charge records: 19 View all charges
Employees and EPFO Compliance at Biorad Medisys Private Limited
View historical data on people associated with Biorad Medisys Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Biorad Medisys Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Biorad Medisys Private Limited
GSTIN & GST Filing Data of Biorad Medisys Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Biorad Medisys Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Biorad Medisys Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Biorad Medisys Private Limited
MSME Payment Delays by Biorad Medisys Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Biorad Medisys Private Limited
Subsidiaries & Group Companies of Biorad Medisys Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Biorad Medisys Private Limited with ownership details.
MCA Filings & Documents of Biorad Medisys Private Limited
MCA Filings & Documents of Biorad Medisys Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Biorad Medisys Private Limited
Recent News on Biorad Medisys Private Limited
Frequently Asked Questions about Biorad Medisys Private Limited
Biorad Medisys Private Limited is an active private limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 13 March 2000 (26+ years old) and is registered under CIN U33111MH2000PTC265335. The company has 572 employees.
Biorad Medisys Private Limited reported revenue of ₹556.96 Cr for FY 2025 (up 52.00% YoY).
The current directors of Biorad Medisys Private Limited are:
The primary industry of Biorad Medisys Private Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.
Biorad Medisys Private Limited can be reached at the registered office: No.221 Damji Shamji Industrial Complex Near Golden Palace Hotel 9Lbs Marg Kur, LaW, Mumbai, Maharashtra, India – 400070, or through the website biorad-medisys.com.
The authorised capital is ₹3 Cr, and the paid-up capital is ₹1.22 Cr.